Dr. Centeno to be keynote speaker at STEMSO Conference

[barbara]

Westin Beach Resort and Spa

February 6-8, 2013
Fort Lauderdale, Florida

2013 STEMSO Agenda

Call STEMSO to Register 803-589-904
WWW.STEMSO.ORG
The International Stem Cell Society, STEMSO, is a member based, international, non-profit 501(c) 6 trade association for the purpose of promoting the interests of the global, adult stem cell healthcare industry while linking patients with member medical organizations. STEMSO provides information, education, resources and advocacy for the advancement of adult stem cell treatment options for doctors and patients with a wide range of chronic illnesses and cultural backgrounds.


Wednesday, February 6, 2012
Board Meeting
10:00 a.m.Prospective Member Meeting
STEMSO Member By-Laws, Membership Dues, and Guidelines
State Legislative Priorities and Requirements
Membership Directory and Clinic Locator
Minimum Standards for Membership Directory
Nomination for 2013 Committee Chair and Advisory Chair Members
1:00 p.m General Sessions Begin
David S. Smith, Attorney at Law
6:00 p.m. Opening Night Reception

Thursday February 7, 2013
Keynote Speaker, Christopher Centeno, MD, Ph.D
Jaraslov Michelek MD, Ph.D
Keith March, MD, Ph.D
Andrew Ittleman, Attorney at Law
Vijendra Singh MD, Ph.D

Friday February 8, 2013
Speakers TBA
11:30 a.m. Closing Remarks

Prospective Member's Meeting
Join us for our Prospective Member's Meeting, Wednesday, Feb. 6 at 10:00 am to discuss how patients can locate legitimate member clinics and research trials in the United States and abroad which offer stem cell treatments for their unique medical conditions through our Member and Clinic Locator, member guidelines,nominations and election of STEMSO Advisory Committee Members.

 

[barbara]

Neil Riordan, PhD added as speaker

STEMSO welcomes Neil Riordan, Ph.D. as speaker at the 2013 STEMSO Conference. Dr. Riordan, Chairman of Medistem Panama and Founder of the Stem Cell Institute in Panama City, Panama, is a well-respected scientist with over 55 peer-reviewed articles and 25 US patents approved or pending. Dr. Riordan has been invited to review 15 different journals in the field of regenerative medicine. At the Stem Cell Institute, Dr. Riordan's mission is to be at the forefront of research of new treatment protocols for chronic diseases using adult stem cells, always according to the highest international bioethics standards, and offering, with transparency, honesty and human quality, treatments developed to improve the condition of patients.

Conference Registration Discount Register Online or Call STEMSO 803-412-4590
Book Hotel Online or Call Westin 954-467-1111

 

[barbara]

Conference schedule

STEMSO 2013 CONFERENCE AGENDA
Wednesday, February 6, 2012

STEMSO Board Meeting Prospective Members Meeting

General Sessions Begin

Welcoming Remarks 4:00 p.m. Doug Hammond, President, STEMSO

Patrick Connor, MD OrthoCarolina Sports Clinic
Head Team Physician: Carolina Panthers, Joe Gibbs Racing
Sports Medicine and Stem Cells: Help or Hype? Speaker TBA

Neil Riordan, Ph.D., Chairman, Medistem Panama Mesenchymal Stem Cells in Regenerative Medicine: Mechanisms of action, sources, and delivery options

David S. Smith, Attorney at Law

Opening Night Reception and Networking

Thursday, February 7, 2013

Breakfast in Exhibitor Area

General Sessions Begin

Christopher Centeno, MD Regenexx
Keynote Speaker: Delivering Orthopedic Stem Cell Therapies via a Strict Registry based Approach: The Regenexx Experience

Dr. Allan Wu, MD, FAACS, FACPH Specialty Plastic Surgery
Morrow Institute Chief Scientific Officer
A Novel and FDA Compliant Method of ADSC Use with the United States

Keith March, MD, PhD Professor of Medicine, Physiology and Biomedical Engineering
Director, Vascular and Cardiac Center for Adult Stem Cell Therapy, Indiana University

Mary Ann Chirba, J.D., D.Sc.M.P.H. Boston College Law School Regulation and The Practice of Medicine

Douglas Hammond, President, International Stem Cell Society (STEMSO)

Lunch

Jaroslav Michalek, MD, PhD
Masaryk University, School of Medicine,Brno, Czech Republic Stem cell therapy of osteoarthritis using adipose tissue-derived stromal vascular fraction cells

Andrew Ittleman, Esq., C.A.M.S.
Fuerst, Ittleman, David & Joseph
Litigation and Regulatory Matters with the FDA

Mirjana Pavlovic,M.D.,Ph.D. College of Engineering and Computer Science
Optimizing stem cells for autologous transplant after Acute Miocardial Infarction

Mock Debate: "Who Gets to Decide?"

Jorge Paz Rodriguez, MD
President, Stem Cell Institute Panama City, Panama Clinical Experiences Using Autologous Stromal Vascular Fraction for Inflammation, Autoimmunity and Regeneration

Michael Gilkey, MBA, MS(National Center for Regenerative Medicine) The United States Military Investment in Regenerative Medicine

Wade McKenna, M.D., North Central Texas Orthopedics & Sports Medicine

Poolside Cocktail Reception and Heavy Hors d'oeuvres

Friday, February 8, 2013

***Breakfast in Exhibitor Area***
General Session Begins

Ricardo Luis Rodriguez, MD
International Cellular Medicine Society, President
Clinical Applications of Adipose Derived Stem Cells

Allan Wu, MD, FAACS, FACPH Specialty Plastic Surgery Morrow Institute Chief Scientific Officer Opportunities in FDA Compliance and Point of Care Assays

Panel Discussion: Ethical Patient Recruitment and Marketing

Adam Katz, MD, FACS Univ. of Fl. Plastic and Reconstructive Surgery "Waist Not, Want Not: 16 Years of Fat Thinking"


Karl Nobert, Of Counsel

***Business Casual Attire is Encouraged for all Guests and Speakers***



www.stemso.org

 

[LLL6521]

I am fortunate to live near the conference, so I will be attending the day Dr. Centeno speaks, February 7th. I am looking forward to meeting many of the Doctors mentioned on this forum especially Dr. Centeno. I am proud that we will have some representation as a member of this forum and as an advocate fighting for the rights of our stem cells. I will report back with my experience on this forum.

 

[Donna]

Carry the torch for us LLL6521. I'm glad you can attend.

 

[barbara]

Kristin Comella to speak

STEMSO welcomes Kristin Comella.

Ms. Comella has over 15 years experience in corporate entities with expertise in regenerative medicine, training and education, research, product development, and senior management. Ms. Comella has been a member of the Bioheart Inc. senior management team since 2004 and is currently serving as the Chief Scientific Officer. Bioheart is a publically traded company focusing on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Ms. Comella was appointed as Bioheart's Vice President of R&D and Corporate Development in December 2008. Since joining Bioheart in September 2004, she has played a major role in managing the product development, manufacturing and quality systems. In addition, Ms. Comella is currently and actively serving on multiple boards in the stem cell arena. She is co-founder and Chief Executive Officer of Stemlogix, LLC and Chief Scientific Officer of the Ageless Regenerative Institute. The Ageless and Stemlogix Programs involve education, training, technology and support in delivering regenerative medicine to clinicians and veterinarians. Ms. Comella has years of cell culturing experience including building and managing the stem cell laboratory at Tulane University's Center for Gene Therapy. She also developed stem cell therapies for osteoarthritis at Osiris Therapeutics. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.